Nearly everyone has heard of GLP-1 drugs, but far fewer have actually tried them. Medications like Ozempic and Wegovy have quickly moved from niche medical treatments to cultural mainstays. According to a new study from Reach3 Insights, 92% of Americans are now aware of GLP-1 medications. That’s near total awareness, but actual use tells a different story.
Supply & Demand
Among non-users, more than a third (38%) say they’re interested in trying GLP-1s, yet just 13% of U.S. adults report currently using them. Hype almost certainly accounts for a subset who are open to the idea yet won’t take the next step. But such a high level of interest suggests another factor is at play: demand is outpacing access. Cost, insurance coverage, and availability are likely key barriers. In other words, interest isn’t the issue; logistics are.
Gaining More Than Weight Loss
As celebrities step onto the red carpet with slimmer silhouettes, weight loss dominates the conversation around GLP-1s. Many users in the public sphere are speaking openly about their experience with them, but weight loss isn’t the only reason Americans are using GLP-1s:
For many, these drugs promise more than a smaller number on the scale. They signal control. In a culture obsessed with having the “perfect” body, where our relationship with food not only influences our health but, for many, our self-image—however detrimental—it’s no wonder why.
That control shows up in daily habits. Fifty-seven percent of users report eating smaller portions, while 44% say they crave junk food less often. One in four say they’re eating out less, and others are choosing low- or no-sugar drinks more often.
More than recalibrating weight loss, GLP-1s are creating lifestyle shifts.
The Psychology of Sustenance
The most interesting changes may not be physical. Users report feeling less constant hunger, fewer intrusive food thoughts, fewer cravings, and easier decision-making around food. For generations raised on diet culture, it reframes the experience from restriction to relief.
But expectations are still high. Among those interested in GLP-1s, 77% expect to lose weight, and many also anticipate improved energy and overall well-being. Reality, however, is more nuanced.
Food for Thought
GLP-1s aren’t without downsides. Reported side effects range from mild nausea to severe gastrointestinal issues. Some users say the impact on daily life isn’t always manageable, and others report plateauing after initial weight loss. A few say results are temporary or less dramatic than expected.
However, confidence is still high. Of those using GLP-1s, 69% recommend them. The vast majority of current users are still early in their journey, with 74% using GLP-1s for a year or less. That means long-term outcomes are still unfolding.
GLP-1s sit at an interesting intersection of health, culture, and accessibility. They offer a new way to approach weight and metabolic health. But they also raise questions about expectations, sustainability, and larger cultural conversations around how we perceive bodies.
The takeaway isn’t that GLP-1s are a miracle or a mistake. It’s that they’re complex. And like most things in modern wellness, the reality lives somewhere in between.
Health trends are changing fast. Join Angus Reid USA to share your perspective on the issues shaping everyday life and earn rewards for your opinion.
